Pay in 4 interest-free payments of $6.95 Learn more
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
ESPECIALISTAS EN DIABETES DIRECCIN: Pasteur 532 CABA TELFONO: 011 4959-3100 EMAIL: [email protected]
doi:10.3760/cma.j.issn.1009-2587.2019.08.014
Key Points Weight loss diabetes drugs like Ozempic, Wegovy (semaglutide), Zepbound, and Mounjaro have been linked to rare vision issues Research on people taking semaglutide (Ozempic and Wegovy) showed an increased risk of NAION (a type of eye nerve stroke) and other serious eye conditions NAION risk is very rare, affecting up to 1 in 10,000 people taking semaglutide, according to the European Medicines Agency (EMA) There is no conclusive proof that the medications are a direct cause of vision problems If you experience any vision changes or issues, please get medical care immediately and let your healthcare provider know about your symptoms Medications like Ozempic, Wegovy, Zepbound, and Mounjaro changed how many people manage type 2 diabetes and weight gain
the NIHR 'Be Part of Research' portal lists currently recruiting UK studies
